Studies presented at AMP Global conference in Berlin reaffirm powerful analytical performance and ease of use for the world’s first complete Sample to Insight NGS solution Hilden, Germany, April 3, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced further validation of the GeneReader NGS System with the publication of five new… Read article →
The inaugural AMP Global Congress on Molecular Pathology, hosted by the Association for Medical Pathologists (AMP), is the event of the year for molecular pathology, diagnostic technologies and research and clinical applications. AMP Global 2017 is the perfect event for QIAGEN to remind and educate the market about our broad menu of Sample to Insight… Read article →
We’re excited to join @tbcontrollers at the 2018 National TB Conference in Palm Springs, CA to discuss changes in… https://t.co/zGstE5FNa0, Thank you @AMPath and all visitors for a great and insightful event in Rotterdam. We are looking forward to see you… https://t.co/GbVNualoEQ, QIAGEN reports results for first quarter 2018
https://t.co/WzAhoClXyy https://t.co/5FY4StmXeb, QIAGEN CEO Peer Schatz talked with us at #AMPeurope2018 about the importance of the conference, engaging with inter… https://t.co/5Ve12ahISy, Learn more about the first complete Sample to Insight #NGS solution designed for any research lab to deliver action… https://t.co/pPTXSQymv7, 